Re: OTC Expert & Grey Market Restrictions
in response to
by
posted on
Nov 22, 2022 11:50AM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
I will be testing this ruling tomorrow morning.
This is the only warning I've been getting when placing orders to date with Scotia iTRADE.
"Warning! US OTC pink sheet quotes are only indications of the market price and do not represent firm quotes."
Koo